Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00935090 : 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
PhaseN/A
AgesMin: 18 Years Max: 120 Years
Eligibility
DISEASE CHARACTERISTICS:

- Meets one of the following criteria:

- Histologically confirmed solid tumor or hematologic malignancy

- Awaiting biopsy or surgery for cancer evaluation of a mass detected on exam or
standard imaging

PATIENT CHARACTERISTICS:

- Able to lie still in the PET scanner

- Girth and weight must be suitable to enter the gantry

- Not pregnant or nursing

- Negative pregnancy test

- Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY:

- Not specified
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00935090      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740